| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue | ||||||
3,781 | 2,849 | 1,754 | ||||
Cost of revenue | ||||||
2,004 | 1,201 | 488 | ||||
Gross profit | ||||||
1,777 | 1,648 | 1,266 | ||||
Selling, general, and administrative expenses | ||||||
82,166 | 50,902 | 46,886 | ||||
Research and development expenses | ||||||
132,873 | 117,932 | 93,085 | ||||
Operating loss | ||||||
-213,262 | -167,186 | -138,705 | ||||
Interest income | ||||||
2,297 | 633 | 241 | ||||
Interest expense | ||||||
36 | 10 | 21 | ||||
Other income | ||||||
128 | 28,571 | 453 | ||||
Loss before income taxes | ||||||
-210,873 | -137,992 | -138,032 | ||||
Income tax (benefit) expense | ||||||
62 | 147 | 155 | ||||
Net loss | ||||||
-210,935 | -138,139 | -138,187 | ||||
Other comprehensive loss: | ||||||
Foreign currency translation adjustment | ||||||
-23 | -52 | -21 | ||||
Total comprehensive loss | ||||||
-210,958 | -138,191 | -138,208 | ||||
Net loss per share: | ||||||
Basic and diluted (in dollars per share) | ||||||
-1.09 | -0.71 | -0.71 | ||||
Weighted-average shares outstanding | ||||||
Basic and diluted (in shares) | ||||||
194,378 | 193,663 | 193,663 | ||||